Brii Biosciences Limited (BRIBF)
USD 0.18
(46.03%)
USD 0.18
(46.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.19 Billion CNY | -5.71% |
| 2022 | 3.39 Billion CNY | -6.09% |
| 2021 | 3.61 Billion CNY | 184.85% |
| 2020 | 1.26 Billion CNY | 21.99% |
| 2019 | 1.03 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.89 Billion CNY | -9.43% |
| 2024 Q2 | 2.89 Billion CNY | 0.0% |
| 2023 Q2 | 3.19 Billion CNY | 0.0% |
| 2023 FY | 3.19 Billion CNY | -5.71% |
| 2023 Q4 | 3.19 Billion CNY | 0.0% |
| 2023 Q1 | 3.19 Billion CNY | -5.7% |
| 2023 Q3 | 3.19 Billion CNY | -0.0% |
| 2022 Q1 | 3.47 Billion CNY | -3.87% |
| 2022 FY | 3.39 Billion CNY | -6.09% |
| 2022 Q4 | 3.39 Billion CNY | 0.0% |
| 2022 Q3 | 3.39 Billion CNY | -2.3% |
| 2022 Q2 | 3.47 Billion CNY | 0.0% |
| 2021 Q1 | 1.66 Billion CNY | 31.66% |
| 2021 FY | 3.61 Billion CNY | 184.85% |
| 2021 Q2 | 1.66 Billion CNY | 0.0% |
| 2021 Q3 | 3.61 Billion CNY | 116.35% |
| 2021 Q4 | 3.61 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 1.26 Billion CNY | 21.99% |
| 2020 Q4 | 1.26 Billion CNY | 0.0% |
| 2020 Q3 | 1.26 Billion CNY | 0.0% |
| 2019 FY | 1.03 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 52.7 Million USD | -5968.672% |
| Skye Bioscience, Inc. | 11.94 Million USD | -26685.1% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -2356.211% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -579167.369% |
| Qrons Inc. | 420.00 USD | -761488233.333% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -21865.571% |
| CSL Limited | 38.02 Billion USD | 91.588% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -30203.686% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -163226.982% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -904339.266% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -11345.215% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -665430.0% |
| Rebus Holdings, Inc. | 5000.00 USD | -63964920.0% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -138452324.242% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -414910.173% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -465109.619% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -8132.942% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -44198.566% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -4188614.409% |
| SQZ Biotechnologies Company | 107.18 Million USD | -2883.805% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -223236.56% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -4419510.309% |
| Mesoblast Limited | 667.9 Million USD | -378.851% |
| Marizyme, Inc. | 22.01 Million USD | -14427.55% |
| Genus plc | 1.02 Billion USD | -210.842% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -235350.652% |
| Pharming Group N.V. | 462.85 Million USD | -590.985% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -96436.052% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -640781.975% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -509987.879% |
| ContraFect Corporation | 20.67 Million USD | -15366.178% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -819195.482% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -836750.726% |
| IMV Inc. | 31.33 Million USD | -10107.036% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -77040.232% |
| MultiCell Technologies, Inc. | 126.22 USD | -2533870126.588% |
| ONE Bio Corp. | 70.08 Million USD | -4463.356% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -340252.074% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -2388.718% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -740726.334% |
| Q BioMed Inc. | 3.51 Million USD | -90875.268% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -8991.364% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -1223984.401% |
| Biomind Labs Inc. | 73.81 Thousand USD | -4332458.014% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -616.6% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -220645.174% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -10555.526% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -116355.239% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -122758.632% |
| GB Sciences, Inc. | 103.44 Thousand USD | -3091730.204% |
| Alpha Cognition Inc. | 2.45 Million USD | -130325.338% |
| HST Global, Inc. | 1526.00 USD | -209583844.954% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -323620.428% |
| Halberd Corporation | 10.13 Thousand USD | -31568856.668% |
| Enzolytics Inc. | 361.7 Million USD | -784.211% |
| Agentix Corp. | 261.39 Thousand USD | -1223445.862% |
| Resverlogix Corp. | 8.11 Million USD | -39311.596% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -170211.788% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 29.592% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -6604.648% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -499895.466% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -14039015.93% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -35638.022% |
| AVAX Technologies, Inc. | 7.37 Million USD | -43253.435% |
| Zenith Capital Corp. | 7410.00 USD | -43161182.051% |
| Genscript Biotech Corporation | 3.38 Billion USD | 5.556% |
| Ember Therapeutics, Inc. | 184.00 USD | -1738179791.304% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -993744.428% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -1223576.941% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -344553.601% |
| Kadimastem Ltd | 2.3 Million USD | -138708.158% |
| Helix BioMedix, Inc. | 3.02 Million USD | -105624.3% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -5601628.728% |
| LadRx Corporation | 2.3 Million USD | -138479.485% |
| Cell Source, Inc. | 195.17 Thousand USD | -1638591.711% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -904339.266% |
| NovAccess Global Inc. | 62.24 Thousand USD | -5137817.684% |
| Affymax, Inc. | 7.44 Million USD | -42869.918% |
| Itoco Inc. | 1.4 Million USD | -228334.752% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -3343357.353% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -3017117.925% |
| Mobile Lads Corp. | 52.00 USD | -6150482592.308% |
| CytoDyn Inc. | 11.13 Million USD | -28619.926% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -2236877.17% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -17887209.843% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -829599.51% |
| SYBLEU INC | 330.46 Thousand USD | -967694.461% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -781062.468% |
| International Stem Cell Corporation | 5.39 Million USD | -59236.753% |
| Bioxytran, Inc. | 137.63 Thousand USD | -2323568.609% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -21219.072% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -19190.977% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -4048318.987% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -369778.116% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -42446.907% |
| Neutra Corp. | 2851.00 USD | -112179871.94% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -9769.317% |
| PureTech Health plc | 693.97 Million USD | -360.861% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -39526.016% |
| IXICO plc | 15.84 Million USD | -20086.005% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -38516.892% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -2995.361% |
| CSL Limited | 38.02 Billion USD | 91.588% |
| Cellectis S.A. | 333.99 Million USD | -857.576% |